Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
Objective: To investigate the diagnostic value of serological testing and dynamic variance of serum antibody in coronavirus disease 2019 (COVID-19). Methods: This study retrospectively included 43 patients with a laboratory-confirmed infection and 33 patients with a suspected infection, in whom the disease was eventually excluded. The IgM/IgG titer of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was measured by chemiluminescence immunoassay analysis. Results: Compared to molecular detection, the sensitivities of serum IgM and IgG antibodies to diagnose COVID-19 were 48.1% and 88.9%, and the specificities were 100% and 90.9%, respectively.In the COVID-19 group, the IgM-positive rate increased slightly at first and then decreased over time; in contrast, the IgG-positive rate increased to 100% and was higher than IgM at all times. The IgM-positive rate and titer were not significantly different before and after conversion to virus-negative. The IgG-positive rate was up to 90% and not significantly different before and after conversion to virus-negative. However, the median IgG titer after conversion to virus-negative was double that before, and the difference was significant. Conclusions: Viral serological testing is an effective means of diagnosis for SARS-CoV-2 infection. The positive rate and titer variance of IgG are higher than those of IgM in COVID-19..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
---|---|
Enthalten in: |
International Journal of Infectious Diseases - 94(2020), Seite 49-52 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yujiao Jin [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
doi: |
10.1016/j.ijid.2020.03.065 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ006233783 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ006233783 | ||
003 | DE-627 | ||
005 | 20230309200802.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2020.03.065 |2 doi | |
035 | |a (DE-627)DOAJ006233783 | ||
035 | |a (DE-599)DOAJ9b8ab5c1c12f45a5a885556af9472af5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC109-216 | |
100 | 0 | |a Yujiao Jin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Objective: To investigate the diagnostic value of serological testing and dynamic variance of serum antibody in coronavirus disease 2019 (COVID-19). Methods: This study retrospectively included 43 patients with a laboratory-confirmed infection and 33 patients with a suspected infection, in whom the disease was eventually excluded. The IgM/IgG titer of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was measured by chemiluminescence immunoassay analysis. Results: Compared to molecular detection, the sensitivities of serum IgM and IgG antibodies to diagnose COVID-19 were 48.1% and 88.9%, and the specificities were 100% and 90.9%, respectively.In the COVID-19 group, the IgM-positive rate increased slightly at first and then decreased over time; in contrast, the IgG-positive rate increased to 100% and was higher than IgM at all times. The IgM-positive rate and titer were not significantly different before and after conversion to virus-negative. The IgG-positive rate was up to 90% and not significantly different before and after conversion to virus-negative. However, the median IgG titer after conversion to virus-negative was double that before, and the difference was significant. Conclusions: Viral serological testing is an effective means of diagnosis for SARS-CoV-2 infection. The positive rate and titer variance of IgG are higher than those of IgM in COVID-19. | ||
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Diagnosis | |
650 | 4 | |a Serological test | |
650 | 4 | |a Immunoglobulin M | |
650 | 4 | |a Immunoglobulin G | |
653 | 0 | |a Infectious and parasitic diseases | |
700 | 0 | |a Miaochan Wang |e verfasserin |4 aut | |
700 | 0 | |a Zhongbao Zuo |e verfasserin |4 aut | |
700 | 0 | |a Chaoming Fan |e verfasserin |4 aut | |
700 | 0 | |a Fei Ye |e verfasserin |4 aut | |
700 | 0 | |a Zhaobin Cai |e verfasserin |4 aut | |
700 | 0 | |a Ying Wang |e verfasserin |4 aut | |
700 | 0 | |a Huaizhong Cui |e verfasserin |4 aut | |
700 | 0 | |a Kenu Pan |e verfasserin |4 aut | |
700 | 0 | |a Aifang Xu |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 94(2020), Seite 49-52 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
773 | 1 | 8 | |g volume:94 |g year:2020 |g pages:49-52 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2020.03.065 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/9b8ab5c1c12f45a5a885556af9472af5 |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971220301983 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 94 |j 2020 |h 49-52 |